SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): March 17, 2004
----------------
Strategic Diagnostics Inc.
-----------------------------------------------
(Exact Name of Registrant Specified in Charter)
Delaware 000-68440 56-1581761
---------------- ---------------- -------------------
(State or Other (Commission File (I.R.S. Employer
Jurisdiction of Number) Identification No.)
Incorporation)
111 Pencader Drive
Newark, DE 19702
---------------------------------------- ----------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (302) 456-6789
---------------
ITEM 12. Results of Operations and Financial Condition.
On March 17, 2004, Strategic Diagnostics Inc. issued a press release
announcing that it had entered into a long-term joint marketing and services
agreement with Epitomics, Inc. A copy of that press release is being furnished
as Exhibit 99.1 to this report.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
STRATEGIC DIAGNOSTICS INC.
By: /s/ Stanley J. Musial
------------------------------
Stanley J. Musial
Chief Financial Officer
Dated: March 19, 2004
2